Medicare Enrolled

Dr. Animesh Petkar, M.D.

Ophthalmology · Fresno, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
6767 NORTH FRESNO AVE, # 101, Fresno, CA 93710
5594321000
In practice since 2008 (17 years)
NPI: 1417121054 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Petkar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Petkar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Petkar

Dr. Animesh Petkar is an ophthalmology specialist in Fresno, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Petkar performed 1,924 Medicare services across 1,388 unique beneficiaries.

Between the years covered by Open Payments, Dr. Petkar received a total of $44,332 from 18 pharmaceutical and/or device companies across 58 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Petkar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 48% volume in CA $44,332 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,924
Medicare services
Top 48% in CA for ophthalmology
1,388
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~113 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
639 $58 $275
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
323 $29 $300
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
291 $25 $300
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
134 $54 $250
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
132 $89 $1,098
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
91 $57 $398
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
89 $47 $250
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
85 $24 $300
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
52 $98 $400
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
38 $101 $515
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
30 $17 $250
Retinal laser treatment for leaking blood vessels
This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels.
20 $277 $1,700
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$44,332
Total received (2018-2024)
Avg $6,333/year across 7 years
Top 7% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
18
Companies
58
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$43,335 (97.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$722 (1.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$275 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$124
2023
$17,035
2022
$26,480
2021
$119
2020
$55
2019
$211
2018
$308

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$90
Dompe US, Inc.
$18
Oyster Point Pharma, Inc.
$16
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Baxter Healthcare
$43,335
Welch Allyn
$275
Aerie Pharmaceuticals, Inc.
$108
Amgen Inc.
$90
Horizon Therapeutics plc
$87
Astellas Pharma US Inc
$52
Mallinckrodt Hospital Products Inc.
$49
Dompe US, Inc.
$48
Novartis Pharmaceuticals Corporation
$45
Sun Pharmaceutical Industries Inc.
$42
Alcon Vision LLC
$38
Genentech USA, Inc.
$35
Merz North America, Inc.
$33
Alimera Sciences, Inc.
$22
TissueTech, Inc.
$22
Shire North American Group Inc
$20
Allergan, Inc.
$16
Oyster Point Pharma, Inc.
$16
Top 3 companies account for 98.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · CEQUA · Constellation · Hillrom - RetinaVue 700 Imager · ILUVIEN · LUMIGAN · OXERVATE · Prokera · RetinaVue Network · Rhopressa · SUSVIMO · TEPEZZA · TYRVAYA · VABYSMO · XELPROS · XEOMIN · XIIDRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (98%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 7% for ophthalmology in CA.

Looking for an ophthalmology specialist in Fresno?
Compare ophthalmologists in the Fresno area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
46
Per 100K population
4.5
County median income
$71,434
Nearest hospital
FRESNO SURGICAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Petkar is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 7% of CA peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Petkar experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Petkar performed 639 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Petkar receive payments from pharmaceutical companies?
Yes. Dr. Petkar received a total of $44,332 from 18 companies across 58 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Petkar's costs compare to other ophthalmologists in Fresno?
Dr. Petkar's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Petkar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →